
Please try another search
JetBlue Airways Corporation (NASDAQ:JBLU) will launch an additional flight to Guayaquil, Ecuador, beginning Dec 5, 2019. Once operational, this nonstop daily flight from New York’s John F. Kennedy International Airport will be the longest route in JetBlue’s network. Tickets on the route are currently available for sale.
The new service will expand JetBlue’s base in Ecuador as well as in South America. This February, the carrier commenced operations in Guayaquil from Fort Lauderdale. (Read more: JetBlue Boosts South American Base With Flights to Guayaquil). Additionally, the airline operates daily between Fort Lauderdale and Quito. Notably, Guayaquil marks the sixth city served by JetBlue in South America.
The airline’s move to penetrate the prosperous Ecuador market is noteworthy as it tries to attract traffic on the New York-Guayaquil route, which “suffers from high fares and limited service choices”.
The carrier will operate on the route via the fuel-efficient Airbus A321neo aircraft featuring premium facilities, such as luxurious seating and infight entertainment services for an enhanced customer experience.
Zacks Rank & Key Picks
JetBlue carries a Zacks Rank #3 (Hold). Some better-ranked stocks in the broader Transportation sector are SkyWest, Inc. (NASDAQ:SKYW) , GATX Corporation (NYSE:GATX) and Fly Leasing Limited (NYSE:FLY) . While Fly Leasing sports a Zacks Rank #1 (Strong Buy), SkyWest and GATX carry a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
Shares of SkyWest and Fly Leasing have surged more than 35% and 55%, respectively, so far this year. Meanwhile, GATX flaunts a stellar earnings history, having surpassed the Zacks Consensus Estimate in each of the preceding four quarters, the average being 16%.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.
See these 7 breakthrough stocks now>>
The markets have been sluggish this week as investors hope for a jolt later in the week when AI juggernaut NVIDIA Corporation (NASDAQ:NVDA) reports fourth quarter and year-end...
On Friday, a wave of selling pressure swept across the US equity markets, leaving a trail of losses. The S&P 500 closed down 1.7%, the DOW slid 1.69%, and the NASDAQ tumbled a...
Palantir remains highly valued with a 460x P/E ratio and a 42.5x P/B ratio, far above its peers. The stock's beta of 2.81 signals high volatility, meaning sharp moves in both...
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review
Add a Comment
We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:
Enrich the conversation, don’t trash it.
Stay focused and on track. Only post material that’s relevant to the topic being discussed.
Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.
Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.